​

Funding Round

Venture Round - Monument Therapeutics

Venture Round - Monument Therapeutics

Investment Firm

Overview

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

Announced Date

Apr 18, 2024

Funding Type

Series Unknown

Highlights

Location

Europe

Social

Investor Lead

Cambridge Angels group

Cambridge Angels group

Cambridge Angels group is a early_stage_venture and late_stage_venture and seed and venture firm.

Participant Investors

3

Investor Name
Participant InvestorManchester Angels
Participant InvestorSyndicateRoom
Participant InvestorCambridge Angels group

Round Details and Background

Monument Therapeutics raised $1243549 on 2024-04-18 in Venture Round

Monument Therapeutics develops products to treat serious diseases of the central nervous system.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jul 01, 2021
Seed Round - Monument Therapeutics
4-3.6M
Apr 18, 2024
Venture Round - Monument Therapeutics
3-1.2M
Apr 18, 2024
Grant - Monument Therapeutics
1-621.8K

Recent Activity

There is no recent news or activity for this profile.